Articles |
From the Department of Medicine (M.M.P., C.S.L., S.Y.), Division of Cardiovascular Disease; the Department of Physiology and Biophysics (G.R.H.); and the Department of Pathology (P.G.A.), Division of Molecular/Cellular Pathology; University of Alabama at Birmingham.
Correspondence to Dr M.M. Pike, Department of Medicine, Division of Cardiovascular Disease, 703 S 19th Street, ZRB 308, Birmingham, AL 35294-0007.
Abstract To clarify the role of
Na+i, pHi, and
high-energy phosphate (HEP) levels in the initiation and
maintenance of ischemia-induced ventricular
fibrillation (VF), interleaved 23Na and 31P
nuclear magnetic resonance spectra were collected on perfused rat
hearts during low-flow ischemia (51 minutes, 1.2 mL/g wet wt).
When untreated, 50% of the hearts from normal (sham) rats and 89% of
the hypertrophied hearts from aortic-banded (band) rats
(P<.01 versus sham) exhibited VF. Phosphocreatine content
was significantly higher in sham than band hearts during control
perfusion (53.3±1.6 versus 39.8±2.0 µmol/g dry wt). Before VF at 20
minutes of ischemia, Na+i accumulation
was greater in hearts that eventually developed VF than in hearts that
did not develop VF for both band and sham groups (144% versus 128% of
control in sham; P<.005) and was the strongest
metabolic predictor of VF; ATP depletion was also greater
for VF hearts in the sham group. Infusion of the
Na+-H+ exchange inhibitor
5-(N,N-hexamethylene)-amiloride prevented
VF in sham and band hearts; reduced Na+i
accumulation but similar HEP depletion were observed compared with VF
hearts before the onset of VF. Rapid changes in
Na+i, pHi, and HEP
began with VF, resulting in intracellular Na+i
overload (
300% of control) and increased HEP depletion. A delayed
postischemic functional recovery occurred in VF hearts,
which correlated temporally with the recovery of
Na+i. In conclusion, alterations in
Na+i were associated with spontaneous VF
transitions, consistent with involvement of excess
Na+i accumulation in VF initiation and
maintenance and with previously reported alterations in
Ca2+i with VF. Hypertrophied band hearts
exhibited enhanced susceptibility to ischemia-induced VF,
possibly linked to a lower HEP reserve.
Key Words: ventricular fibrillation intracellular Na+ ischemia nuclear magnetic resonance cardiac hypertrophy
This article has been cited by other articles:
![]() |
K. Zerumsky and B. F. McBride Ranolazine in the management of chronic stable angina Am. J. Health Syst. Pharm., December 1, 2006; 63(23): 2331 - 2338. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Davies, S. B. Digerness, S. P. Goldberg, C. R. Killingsworth, C. R. Katholi, P. S. Brookes, and W. L. Holman Intra-myocyte ion homeostasis during ischemia-reperfusion injury: effects of pharmacologic preconditioning and controlled reperfusion Ann. Thorac. Surg., October 1, 2003; 76(4): 1252 - 1258. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I Bak and J. S Ingwall Contribution of Na+/H+ exchange to Na+ overload in the ischemic hypertrophied hyperthyroid rat heart Cardiovasc Res, March 15, 2003; 57(4): 1004 - 1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-r. Wann, M. H. Weil, S. Sun, W. Tang, and T. Yu Cariporide for Pharmacologic Defibrillation After Prolonged Cardiac Arrest Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2002; 7(3): 161 - 169. [Abstract] [PDF] |
||||
![]() |
L. Dai, P. S. Brookes, V. M. Darley-Usmar, and P. G. Anderson Bioenergetics in cardiac hypertrophy: mitochondrial respiration as a pathological target of NO{middle dot} Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2261 - H2269. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Meszaros, D. Khananshvili, and G. Hart Mechanisms underlying delayed afterdepolarizations in hypertrophied left ventricular myocytes of rats Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H903 - H914. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Gazmuri, I. M. Ayoub, E. Hoffner, and J. D. Kolarova Successful Ventricular Defibrillation by the Selective Sodium-Hydrogen Exchanger Isoform-1 Inhibitor Cariporide Circulation, July 10, 2001; 104(2): 234 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Imahashi, H. Kusuoka, K. Hashimoto, J. Yoshioka, H. Yamaguchi, and T. Nishimura Intracellular Sodium Accumulation During Ischemia as the Substrate for Reperfusion Injury Circ. Res., June 25, 1999; 84(12): 1401 - 1406. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. D. Schepkin, I. O. Choy, and T. F. Budinger Sodium alterations in isolated rat heart during cardioplegic arrest J Appl Physiol, December 1, 1996; 81(6): 2696 - 2702. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yanagida, C.S. Luo, M. Doyle, G.M. Pohost, and M.M. Pike Nuclear Magnetic Resonance Studies of Cationic and Energetic Alterations With Oxidant Stress in the Perfused Heart : Modulation With Pyruvate and Lactate Circ. Res., October 1, 1995; 77(4): 773 - 783. [Abstract] [Full Text] |
||||
![]() |
K. Imahashi, T. Nishimura, J. Yoshioka, and H. Kusuoka Role of Intracellular Na+ Kinetics in Preconditioned Rat Heart Circ. Res., June 8, 2001; 88(11): 1176 - 1182. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |